Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Najmeh Parvin, Ahmad Gholami, Seeram Ramakrishna, Navid Omidifar, Mohsen Moghadami, Wei-Hung Chiang & Sargol Mazraedoost. (2021) Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial. Drug Metabolism Reviews 53:1, pages 141-170.
Read now
Read now
Muhammad Shahbaz Aslam, Iram Gull, Malik Siddique Mahmood, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed & Muhammad Amin Athar. (2020) High yield expression, characterization, and biological activity of IFNα2-Tα1 fusion protein. Preparative Biochemistry & Biotechnology 50:3, pages 281-291.
Read now
Read now
Sujun Sun, Haiyu Ji, Yingying Feng, Yu Kang, Juan Yu & Anjun Liu. (2018) A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma. Cancer Management and Research 10, pages 417-424.
Read now
Read now
Enrico Garaci. (2018) From thymus to cystic fibrosis: the amazing life of thymosin alpha 1. Expert Opinion on Biological Therapy 18:sup1, pages 9-11.
Read now
Read now
Claudia Stincardini, Giorgia Renga, Valeria Villella, Marilena Pariano, Vasilis Oikonomou, Monica Borghi, Marina M. Bellet, Luigi Sforna, Claudio Costantini, Allan L. Goldstein, Enrico Garaci & Luigina Romani. (2018) Cellular proteostasis: a new twist in the action of thymosin α1. Expert Opinion on Biological Therapy 18:sup1, pages 43-48.
Read now
Read now
Claudia Matteucci, Ayele Argaw-Denboba, Emanuela Balestrieri, Alessandro Giovinazzo, Martino Miele, Cartesio D’Agostini, Francesca Pica, Sandro Grelli, Maurizio Paci, Antonio Mastino, Paola Sinibaldi Vallebona, Enrico Garaci & Carlo Tomino. (2018) Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases. Expert Opinion on Biological Therapy 18:sup1, pages 23-31.
Read now
Read now
Francesca Pica, Roberta Gaziano, Ida Antonia Casalinuovo, Gabriella Moroni, Cristina Buè, Dolores Limongi, Cartesio D’Agostini, Carlo Tomino, Roberto Perricone, Anna Teresa Palamara, Paola Sinibaldi Vallebona & Enrico Garaci. (2018) Serum thymosin alpha 1 levels in normal and pathological conditions. Expert Opinion on Biological Therapy 18:sup1, pages 13-21.
Read now
Read now
Walter Mandaliti, Ridvan Nepravishta, Francesca Pica, Paola Sinibaldi Vallebona, Enrico Garaci & Maurizio Paci. (2018) Potential mechanism of thymosin-α1-membrane interactions leading to pleiotropy: experimental evidence and hypotheses. Expert Opinion on Biological Therapy 18:sup1, pages 33-42.
Read now
Read now
Xiaoning Wu, Yiwen Shi, Jialing Zhou, Yameng Sun, Hongxin Piao, Wei Jiang, Anlin Ma, Yongpeng Chen, Mingyi Xu, Wen Xie, Jun Cheng, Shibin Xie, Jia Shang, Jilin Cheng, Qing Xie, Huiguo Ding, Xuqing Zhang, Lang Bai, Mingxiang Zhang, Bingqiong Wang, Shuyan Chen, Hong Ma, Xiaojuan Ou, Jidong Jia & Hong You. (2018) Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study. Expert Opinion on Biological Therapy 18:sup1, pages 61-69.
Read now
Read now
Wilfried Posch, Marion Steger, Doris Wilflingseder & Cornelia Lass-Flörl. (2017) Promising immunotherapy against fungal diseases. Expert Opinion on Biological Therapy 17:7, pages 861-870.
Read now
Read now
Silvia Moretti, Vasileios Oikonomou, Enrico Garaci & Luigina Romani. (2015) Thymosin α1: burying secrets in the thymus. Expert Opinion on Biological Therapy 15:sup1, pages 51-58.
Read now
Read now
Claudia Matteucci, Antonella Minutolo, Michela Pollicita, Emanuela Balestrieri, Sandro Grelli, Gabriella D’Ettorre, Vincenzo Vullo, Ilaria Bucci, Alessandra Luchini, Stefano Aquaro, Paola Sinibaldi-Vallebona, Beatrice Macchi, Carlo Federico Perno, Antonio Mastino & Enrico Garaci. (2015) Thymosin α 1 potentiates the release by CD8+ cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro. Expert Opinion on Biological Therapy 15:sup1, pages 83-100.
Read now
Read now
Enrico Garaci, Francesca Pica, Claudia Matteucci, Roberta Gaziano, Cartesio D’Agostini, Martino Tony Miele, Roberto Camerini, Anna Teresa Palamara, Cartesio Favalli, Antonio Mastino, Annalucia Serafino & Paola Sinibaldi Vallebona. (2015) Historical review on thymosin α1 in oncology: preclinical and clinical experiences. Expert Opinion on Biological Therapy 15:sup1, pages 31-39.
Read now
Read now
Allan L Goldstein & Hynda K Kleinman. (2015) Advances in the basic and clinical applications of thymosin β4. Expert Opinion on Biological Therapy 15:sup1, pages 139-145.
Read now
Read now
Ridvan Nepravishta, Walter Mandaliti, Tommaso Eliseo, Paola Sinibaldi Vallebona, Francesca Pica, Enrico Garaci & Maurizio Paci. (2015) Thymosin α1 inserts N terminus into model membranes assuming a helical conformation. Expert Opinion on Biological Therapy 15:sup1, pages 71-81.
Read now
Read now
Robert S King & Cynthia Tuthill. (2015) Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis. Expert Opinion on Biological Therapy 15:sup1, pages 41-49.
Read now
Read now
Xiaoning Wu, Jidong Jia & Hong You. (2015) Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opinion on Biological Therapy 15:sup1, pages 129-132.
Read now
Read now
Ben Morton, Shaun Harry Pennington & Stephen B Gordon. (2014) Immunomodulatory adjuvant therapy in severe community-acquired pneumonia. Expert Review of Respiratory Medicine 8:5, pages 587-596.
Read now
Read now
Articles from other publishers (61)
Hui Ying, Zhi-Qiang Li, Meng-Pan Li & Wen-Cai Liu. (2023) Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies. Frontiers in Endocrinology 14.
Crossref
Crossref
Michał Zimecki, Iwona Kochanowska, Ewa Zaczyńska, Maja Kocięba, Jolanta Artym, Aleksandra Zambrowicz, Magdalena Matwiejczyk, Monika Besman, Karol Kuchar & Aleksander Skotnicki. (2023) Immunoregulatory actions of calf thymus extract (TFX®) in vitro in relation to its effect on expression of mitogen activated protein kinases. International Immunopharmacology 118, pages 109995.
Crossref
Crossref
Yiting Wei, Yunpeng Zhang, Pengcheng Li, Chunguang Yan & Lixin Wang. (2023) Thymosin α-1 in cancer therapy: Immunoregulation and potential applications. International Immunopharmacology 117, pages 109744.
Crossref
Crossref
Cheng-Lin Guo, Jian-Dong Mei, Yu-Long JiaFan-Yi Gan, Yu-Dong Tang, Cheng-Wu Liu, Zhen Zeng, Zhen-Yu Yang, Sen-Yi Deng, Xing SunLun-Xu Liu. (2021) Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis. Chinese Medical Journal 134:22, pages 2700-2709.
Crossref
Crossref
Alexandr Basov, Liliya Fedulova, Ekaterina Vasilevskaya, Ekaterina Trofimova, Nataliya Murashova & Stepan Dzhimak. (2021) Sus Scrofa immune tissues as a new source of bioactive substances for skin wound healing. Saudi Journal of Biological Sciences 28:3, pages 1826-1834.
Crossref
Crossref
Luca Perico, Ariela Benigni, Federica Casiraghi, Lisa F. P. Ng, Laurent Renia & Giuseppe Remuzzi. (2020) Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature Reviews Nephrology 17:1, pages 46-64.
Crossref
Crossref
Zhenzhen Yang, Jiacheng Guo, Kang Cui, Yabing Du, Huan Zhao, Lili Zhu, Lanling Weng, Wenxue Tang, Jiancheng Guo, Tengfei Zhang, Xiaojing Shi, Hong Zong, Shuiling Jin & Wang Ma. (2020) Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production. Biomedicine & Pharmacotherapy 131, pages 110740.
Crossref
Crossref
Wilfried Posch, Doris Wilflingseder & Cornelia Lass-Flörl. (2020) Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts. Current Clinical Microbiology Reports 7:3, pages 57-66.
Crossref
Crossref
Luigina Romani, Carlo Tomino, Paolo Puccetti & Enrico Garaci. (2020) Off-label therapy targeting pathogenic inflammation in COVID-19. Cell Death Discovery 6:1.
Crossref
Crossref
Renhao Peng, Caoying Xu, Heng Zheng & Xingzhen Lao. (2020) Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo. ACS Omega 5:18, pages 10374-10381.
Crossref
Crossref
Lulu Zhang, Xubiao Wei, Rijun Zhang, Jim N. Petitte, Dayong Si, Zhongxuan Li, Junhao Cheng & Mengsi Du. (2019) Design and Development of a Novel Peptide for Treating Intestinal Inflammation. Frontiers in Immunology 10.
Crossref
Crossref
Valentina Sala, Alessandra Murabito & Alessandra Ghigo. (2019) Inhaled Biologicals for the Treatment of Cystic Fibrosis. Recent Patents on Inflammation & Allergy Drug Discovery 13:1, pages 19-26.
Crossref
Crossref
Yunlong Xu, Yanjun Jiang, Lin Wang, Jiahua Huang, Junmao Wen, Hang Lv, Xiaoli Wu, Chaofan Wan, Chuanxin Yu, Wenjie Zhang, Jiaying Zhao, Yinqi Zhou & Yongjun Chen. (2019) Thymosin Alpha-1 Inhibits Complete Freund’s Adjuvant-Induced Pain and Production of Microglia-Mediated Pro-inflammatory Cytokines in Spinal Cord. Neuroscience Bulletin 35:4, pages 637-648.
Crossref
Crossref
Jasmin Kharazmi‐Khorassani & Ahmad Asoodeh. (2019) Thymosin alpha‐1; a natural peptide inhibits cellular proliferation, cell migration, the level of reactive oxygen species and promotes the activity of antioxidant enzymes in human lung epithelial adenocarcinoma cell line (A549). Environmental Toxicology 34:8, pages 941-949.
Crossref
Crossref
Baseer Ahmad, Quratulain Hanif, Wei Xubiao, Zhang Lulu, Muhammad Shahid, Si Dayong & Zhang Rijun. (2019) Expression and Purification of Hybrid LL-37Tα1 Peptide in Pichia pastoris and Evaluation of Its Immunomodulatory and Anti-inflammatory Activities by LPS Neutralization. Frontiers in Immunology 10.
Crossref
Crossref
Michelle Hong & Antonio Bertoletti. 2019. Viral Hepatitis in Children. Viral Hepatitis in Children
115
132
.
Yu-Ming Wang, Dao-Feng Yang, Ming Wang, Nazia Selzner, Kaveh Farrokhi, Andrzej Chruscinski & Gary Levy. 2019. Acute Exacerbation of Chronic Hepatitis B. Acute Exacerbation of Chronic Hepatitis B
457
497
.
Xutong Shen, Qingqing Li, Fanwen Wang, Jingxiao Bao, Mengting Dai, Heng Zheng & Xingzhen Lao. (2018) Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo. Biomedicine & Pharmacotherapy 108, pages 610-617.
Crossref
Crossref
Fanwen Wang, Caoying Xu, Renhao Peng, Bin Li, Xutong Shen, Heng Zheng & Xingzhen Lao. (2018) Effect of a C-end rule modification on antitumor activity of thymosin α1. Biochimie 154, pages 99-106.
Crossref
Crossref
Erica A. Roesch, David P. Nichols & James F. Chmiel. (2018) Inflammation in cystic fibrosis: An update. Pediatric Pulmonology 53:S3, pages S30-S50.
Crossref
Crossref
Jia Liu, Hermann Bihler, Carlos M Farinha, Nikhil T Awatade, Ana M Romão, Dayna Mercadante, Yi Cheng, Isaac Musisi, Walailak Jantarajit, Yiting Wang, Zhiwei Cai, Margarida D Amaral, Martin Mense & David N Sheppard. (2018) Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule. British Journal of Pharmacology 175:7, pages 1017-1038.
Crossref
Crossref
Valeria Tomati, Emanuela Caci, Loretta Ferrera, Emanuela Pesce, Elvira Sondo, Deborah M. Cholon, Nancy L. Quinney, Susan E. Boyles, Andrea Armirotti, Roberto Ravazzolo, Luis J.V. Galietta, Martina Gentzsch & Nicoletta Pedemonte. (2018) Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia. JCI Insight 3:3.
Crossref
Crossref
P. H. Naylor & M. G. Mutchnick. (2018) Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach. Journal of Viral Hepatitis 25:1, pages 4-9.
Crossref
Crossref
Walter Mandaliti, Ridvan Nepravishta, Francesca Pica, Paola Sinibaldi Vallebona, Enrico Garaci & Maurizio Paci. (2017) Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK. Molecules 22:11, pages 1843.
Crossref
Crossref
Dadong Liu, Zongying Yu, Jiangtao Yin, Yikun Chen, Hao Zhang, Fan Xin, Haiyan Fu & Bing Wan. (2017) Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients. Journal of Critical Care 39, pages 259-266.
Crossref
Crossref
Luigina Romani, Vasilis Oikonomou, Silvia Moretti, Rossana G Iannitti, Maria Cristina D'Adamo, Valeria R Villella, Marilena Pariano, Luigi Sforna, Monica Borghi, Marina M Bellet, Francesca Fallarino, Maria Teresa Pallotta, Giuseppe Servillo, Eleonora Ferrari, Paolo Puccetti, Guido Kroemer, Mauro Pessia, Luigi Maiuri, Allan L Goldstein & Enrico Garaci. (2017) Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nature Medicine 23:5, pages 590-600.
Crossref
Crossref
Claudia Matteucci, Sandro Grelli, Emanuela Balestrieri, Antonella Minutolo, Ayele Argaw-Denboba, Beatrice Macchi, Paola Sinibaldi-Vallebona, Carlo Federico Perno, Antonio Mastino & Enrico Garaci. (2017) Thymosin alpha 1 and HIV-1: recent advances and future perspectives. Future Microbiology 12:2, pages 141-155.
Crossref
Crossref
Fang Liu, Hong-Mei Wang, Tiansheng Wang, Ya-Mei Zhang & Xi Zhu. (2016) The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. BMC Infectious Diseases 16:1.
Crossref
Crossref
F Pica, M S Chimenti, R Gaziano, C Buè, I A Casalinuovo, P Triggianese, P Conigliaro, D Di Carlo, V Cordero, G Adorno, A Volpi, R Perricone & E Garaci. (2016) Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. Clinical and Experimental Immunology 186:1, pages 39-45.
Crossref
Crossref
Eytan R. Barnea, Soren Hayrabedyan, Krassimira Todorova, Osnat Almogi-Hazan, Reuven Or, Joy Guingab, James McElhinney, Nelson Fernandez & Timothy Barder. (2016) PreImplantation factor (PIF*) regulates systemic immunity and targets protective regulatory and cytoskeleton proteins. Immunobiology 221:7, pages 778-793.
Crossref
Crossref
Walter Mandaliti, Ridvan Nepravishta, Paola Sinibaldi Vallebona, Francesca Pica, Enrico Garaci & Maurizio Paci. (2016) New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity. Amino Acids 48:5, pages 1231-1239.
Crossref
Crossref
Walter Mandaliti, Ridvan Nepravishta, Paola Sinibaldi Vallebona, Francesca Pica, Enrico Garaci & Maurizio Paci. (2016) Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier. Biochemistry 55:10, pages 1462-1472.
Crossref
Crossref
Jinqiao Wan, Dengfeng Dou, Hongmei Song, Xian‐Hui Wu Xuemin Cheng & Jin Li. 2016. Lead Generation. Lead Generation
259
306
.
Ya-Juan Wang.Li Yang & Jian-Ping Zuo. (2016) Recent developments in antivirals against hepatitis B virus. Virus Research 213, pages 205-213.
Crossref
Crossref
R. Nepravishta, W. Mandaliti, P.S. Vallebona, F. Pica, E. Garaci & M. Paci. 2016. Thymosins. Thymosins
101
119
.
J.L. Bussiere. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Xingzhen Lao, Bin Li, Meng Liu, Chen Shen, Tingting Yu, Xiangdong Gao & Heng Zheng. (2015) A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects. Apoptosis 20:10, pages 1307-1320.
Crossref
Crossref
Robert G. Gish, Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, David L. Lewis & Thomas Schluep. (2015) Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antiviral Research 121, pages 47-58.
Crossref
Crossref
Mirjam B Zeisel, Julie Lucifora, William S Mason, Camille Sureau, Jürgen Beck, Massimo Levrero, Michael Kann, Percy A Knolle, Monsef Benkirane, David Durantel, Marie-Louise Michel, Brigitte Autran, François-Loïc Cosset, Hélène Strick-Marchand, Christian Trépo, Jia-Horng Kao, Fabrice Carrat, Karine Lacombe, Raymond F Schinazi, Françoise Barré-Sinoussi, Jean-François Delfraissy & Fabien Zoulim. (2015) Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure. Gut 64:8, pages 1314-1326.
Crossref
Crossref
Chao Yuan, Yisheng Zheng, Bo Zhang, LiJuan Shao, Yang Liu, Tian Tian, XiaoBin Gu, Xiangnan Li & KeXing Fan. (2015) Thymosin ?1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1. Biochemical and Biophysical Research Communications 464:1, pages 249-255.
Crossref
Crossref
Yi Wang, Keyu Wang, Jianhua Liang, Hong Yang, Ningning Dang, Xi Yang & Yi Kong. (2014)
Differential expression analysis of mi
RNA
in peripheral blood mononuclear cells of patients with non‐segmental vitiligo
. The Journal of Dermatology 42:2, pages 193-197.
Crossref
Crossref
Chao Ni, Pin Wu, Xianguo Wu, Ting Zhang, Yang Liu, Zhen Wang, Sai Zhang, Fuming Qiu & Jian Huang. (2015) Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression. Cancer Letters 356:2, pages 579-588.
Crossref
Crossref
Xiao-song Xiang, Ning Li, Yun-zhao Zhao, Qiu-rong Li & Jie-shou Li. (2013) Combination Therapy with Thymosin Alpha1 and Dexamethasone Helps Mice Survive Sepsis. Inflammation 37:2, pages 402-416.
Crossref
Crossref
Xingzhen Lao, Meng Liu, Jiao Chen & Heng Zheng. (2013) A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1. PLoS ONE 8:8, pages e72242.
Crossref
Crossref
Sebok Kumar Halder, Hayato Matsunaga, Haruka Yamaguchi & Hiroshi Ueda. (2013) Novel neuroprotective action of prothymosin alpha‐derived peptide against retinal and brain ischemic damages. Journal of Neurochemistry 125:5, pages 713-723.
Crossref
Crossref
Sebok Kumar Halder, Junya Sugimoto, Hayato Matsunaga & Hiroshi Ueda. (2013) Therapeutic benefits of 9-amino acid peptide derived from prothymosin alpha against ischemic damages. Peptides 43, pages 68-75.
Crossref
Crossref
Yun Xia, Hui Luo, Jian Ping Liu & Christian Gluud. (2013) Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jianfeng Wu, Lixin Zhou, Jiyun Liu, Gang Ma, Qiuye Kou, Zhijie He, Juan Chen, Bin Ou-Yang, Minying Chen, Yinan Li, Xiaoqin Wu, Baochun Gu, Lei Chen, Zijun Zou, Xinhua Qiang, Yuanyuan Chen, Aihua Lin, Guanrong Zhang & Xiangdong Guan. (2013) The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Critical Care 17:1, pages R8.
Crossref
Crossref
Luigina Romani, Silvia Moretti, Francesca Fallarino, Silvia Bozza, Loredana Ruggeri, Andrea Casagrande, Franco Aversa, Francesco Bistoni, Andrea Velardi & Enrico Garaci. (2012) Jack of all trades: thymosin ?1 and its pleiotropy. Annals of the New York Academy of Sciences 1269:1, pages 1-6.
Crossref
Crossref
Enrico Garaci, Francesca Pica, Annalucia Serafino, Emanuela Balestrieri, Claudia Matteucci, Gabriella Moroni, Roberta Sorrentino, Manuela Zonfrillo, Pasquale Pierimarchi & Paola Sinibaldi-Vallebona. (2012) Thymosin α1 and cancer: action on immune effector and tumor target cells. Annals of the New York Academy of Sciences 1269:1, pages 26-33.
Crossref
Crossref
Dimitra Benaki, Christos Zikos, Chrysoula-Evangelia Karachaliou, Ourania Tsitsilonis, Leondios Leondiadis, Hubert Kalbacher, Wolfgang Voelter, Minas Papadopoulos, Ioannis Pirmettis, Maria Pelecanou & Evangelia Livaniou. (2012)
Complexes of an Alpha Thymosin Derivative with
185/187
Re and
99m
Tc: Structural Analysis and Initial Biological Evaluation
. Chemical Biology & Drug Design 80:4, pages 545-553.
Crossref
Crossref
Mauricio Urquiza, Tatiana Guevara, Cristina Rodriguez, Johanna Melo-Cardenas, Magnolia Vanegas & Manuel E. Patarroyo. (2011) Decreasing the configurational entropy and the hydrophobicity of EBV-derived peptide 11389 increased its antigenicity, immunogenicity and its ability of inducing IL-6. Amino Acids 42:6, pages 2165-2175.
Crossref
Crossref
A. Carvalho, C. Cunha, F. Bistoni & L. Romani. (2012) Immunotherapy of aspergillosis. Clinical Microbiology and Infection 18:2, pages 120-125.
Crossref
Crossref
Xia Yang, Feng Qian, Hai-Yang He, Kai-Jun Liu, Yuan-Zhi Lan, Bing Ni, Yi Tian, Xiao-Lan Fu, Ji Zhang, Zi-Gang Shen, Jian Li, Yi Yin, Jin-Tao Li & Yu-Zhang Wu. (2012) Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro. Brazilian Journal of Medical and Biological Research 45:1, pages 25-32.
Crossref
Crossref
Lijie Cui, Yuhui Chen, Guoan Shen, Lingxia Zhao & Kexuan Tang. (2010) Expression of Bioactive Thymosin Alpha 1 (Tα1) in Marker-free Transgenic Lettuce (Lactuca sativa). Plant Molecular Biology Reporter 29:2, pages 466-472.
Crossref
Crossref
Elke Wolf, Stefania Milazzo, Katja Boehm, Marcel Zwahlen & Markus Horneber. (2011) Thymic peptides for treatment of cancer patients. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Crossref
K. Noel Masihi. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology
411
435
.
Juan Li, Chun Hui Liu & Feng Shan Wang. (2010) Thymosin alpha 1: Biological activities, applications and genetic engineering production. Peptides 31:11, pages 2151-2158.
Crossref
Crossref
Claudia Matteucci, Antonella Minutolo, Paola Sinibaldi‐Vallebona, Anna Teresa Palamara, Guido Rasi, Antonio Mastino & Enrico Garaci. (2010)
Transcription profile of human lymphocytes following
in vitro
treatment with thymosin alpha‐1
. Annals of the New York Academy of Sciences 1194:1, pages 6-19.
Crossref
Crossref
Roman S. Esipov, Vasily N. Stepanenko, Ksenia A. Beyrakhova, Tatjana I. Muravjeva & Anatoly I. Miroshnikov. (2010) Production of thymosin α1 via non‐enzymatic acetylation of the recombinant precursor. Biotechnology and Applied Biochemistry 56:1, pages 17-25.
Crossref
Crossref
Christopher B. Heward. 2010. The Future of Aging. The Future of Aging
227
278
.